Rakuten Investment Management Inc. Acquires New Position in The Cooper Companies, Inc. $COO

by · The Cerbat Gem

Rakuten Investment Management Inc. bought a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO – Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 165,424 shares of the medical device company’s stock, valued at approximately $11,341,000. Rakuten Investment Management Inc. owned 0.08% of Cooper Companies at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in COO. J.Safra Asset Management Corp increased its stake in shares of Cooper Companies by 204.8% in the second quarter. J.Safra Asset Management Corp now owns 506 shares of the medical device company’s stock worth $36,000 after purchasing an additional 340 shares in the last quarter. CYBER HORNET ETFs LLC purchased a new position in shares of Cooper Companies during the 2nd quarter valued at $36,000. MUFG Securities EMEA plc purchased a new stake in Cooper Companies in the 2nd quarter worth $42,000. Assetmark Inc. raised its holdings in Cooper Companies by 357.8% during the second quarter. Assetmark Inc. now owns 618 shares of the medical device company’s stock valued at $44,000 after acquiring an additional 483 shares during the period. Finally, Quent Capital LLC bought a new stake in Cooper Companies during the third quarter valued at about $44,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Price Performance

Cooper Companies stock opened at $82.54 on Thursday. The Cooper Companies, Inc. has a 52-week low of $61.78 and a 52-week high of $100.24. The company has a quick ratio of 1.13, a current ratio of 1.89 and a debt-to-equity ratio of 0.30. The firm’s fifty day moving average is $79.83 and its 200 day moving average is $73.91. The company has a market cap of $16.18 billion, a price-to-earnings ratio of 43.90, a PEG ratio of 2.30 and a beta of 1.03.

Cooper Companies (NASDAQ:COO – Get Free Report) last posted its earnings results on Thursday, December 4th. The medical device company reported $1.15 earnings per share for the quarter, topping analysts’ consensus estimates of $1.11 by $0.04. The firm had revenue of $1.07 billion for the quarter, compared to the consensus estimate of $1.06 billion. Cooper Companies had a net margin of 9.16% and a return on equity of 10.02%. The business’s quarterly revenue was up 4.6% on a year-over-year basis. During the same period in the previous year, the firm posted $1.04 EPS. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. Sell-side analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Insider Buying and Selling

In related news, insider Holly R. Sheffield bought 1,230 shares of the company’s stock in a transaction dated Tuesday, December 16th. The stock was purchased at an average price of $80.75 per share, for a total transaction of $99,322.50. Following the acquisition, the insider owned 39,052 shares in the company, valued at $3,153,449. This trade represents a 3.25% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Albert G. White III bought 10,000 shares of the business’s stock in a transaction dated Tuesday, December 16th. The shares were bought at an average cost of $80.80 per share, for a total transaction of $808,000.00. Following the transaction, the chief executive officer owned 236,151 shares in the company, valued at approximately $19,081,000.80. The trade was a 4.42% increase in their position. The SEC filing for this purchase provides additional information. Insiders have bought a total of 16,014 shares of company stock valued at $1,304,416 in the last quarter. 1.98% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several analysts recently issued reports on the company. Piper Sandler reissued an “overweight” rating and set a $94.00 target price (up previously from $83.00) on shares of Cooper Companies in a research note on Friday, December 5th. KeyCorp restated a “sector weight” rating on shares of Cooper Companies in a research note on Friday, December 5th. JPMorgan Chase & Co. lifted their price objective on shares of Cooper Companies from $66.00 to $78.00 and gave the company a “neutral” rating in a research report on Friday, December 5th. Mizuho set a $100.00 target price on shares of Cooper Companies and gave the stock an “outperform” rating in a research report on Friday, December 5th. Finally, Stifel Nicolaus set a $95.00 price target on shares of Cooper Companies and gave the company a “buy” rating in a report on Friday, December 5th. Eight equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Cooper Companies presently has an average rating of “Hold” and an average target price of $90.31.

View Our Latest Stock Analysis on Cooper Companies

Cooper Companies Company Profile

(Free Report)

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.

Read More